James Hollingshead insider trades

Open-market stock purchases and sales by James Hollingshead, Former President and CEO at Insulet Corp, from SEC Form 4 filings since Mar 1, 2013.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -21%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • PODD Insulet Corp: 1 buy, last Apr 28, 2025
  • RMD Resmed Inc: 61 sales, last Dec 1, 2021

Get free alerts when James Hollingshead files a new trade →